Literature DB >> 32798556

Selenium-independent antioxidant and anti-inflammatory effects of thioredoxin reductase inhibition in alveolar macrophages.

Sara Staples1, Stephanie B Wall1, Rui Li1, Trent E Tipple2.   

Abstract

AIMS: Interleukin-1β (IL-1β) contributes to the development of bronchopulmonary dysplasia (BPD). Thioredoxin reductase-1 (Txnrd1) inhibition activates nuclear factor erythroid 2-related factor 2 (Nrf2)-dependent responses. Txnrd1 activity is selenium (Se) dependent and Se deficiency is common in prematurity. Auranofin (AFN), a Txnrd1 inhibitor, decreases IL-1β levels and increases Nrf2 activation in lipopolysaccharide (LPS) treated alveolar macrophages. In lung epithelia, AFN-induced Nrf2 activation is Se dependent. We tested the hypothesis that the effects of Txnrd1 inhibition in alveolar macrophages are Se dependent. MAIN
METHODS: To establish Se sufficient (Se+) and deficient (Se-) conditions, alveolar (MH-S) macrophages were cultured in 2.5% fetal bovine serum (FBS) ± 25 nM Na2SeO3. Se- (2.5% FBS) and Se+ (2.5% FBS + 25 nM Na2SeO3) cells were cultured in the presence or absence of 0.05 μg/mL LPS and/or 0.5 μM AFN. Nrf2 activation was determined by measuring NADPH quinone oxidoreductase-1 (Nqo1) and glutathione levels. IL-1β mRNA (Il1b) and protein levels were measured using qRT-PCR and ELISA. Data were analyzed by ANOVA followed by Tukey's post-hoc. KEY
FINDINGS: We detected an independent effect of AFN, but not LPS, on Nqo1 expression and GSH levels in Se+ and Se- cells. LPS significantly increased Il1b and IL-1β levels in both groups. AFN-mediated attenuation of this effect was not impacted by Se status. SIGNIFICANCE: The beneficial effects of Txnrd1 inhibition in alveolar macrophages are Se-independent and therefore unlikely to be diminished by clinical Se deficiency.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Auranofin; Interleukin-1β; Macrophage; Prematurity; Selenium; Thioredoxin; Thioredoxin reductase

Mesh:

Substances:

Year:  2020        PMID: 32798556      PMCID: PMC9308397          DOI: 10.1016/j.lfs.2020.118285

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   6.780


  19 in total

1.  Aurothioglucose does not improve alveolarization or elicit sustained Nrf2 activation in C57BL/6 models of bronchopulmonary dysplasia.

Authors:  Qian Li; Rui Li; Stephanie B Wall; Katelyn Dunigan; Changchun Ren; Tamas Jilling; Lynette K Rogers; Trent E Tipple
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-01-25       Impact factor: 5.464

2.  Thioredoxin reductase inhibition elicits Nrf2-mediated responses in Clara cells: implications for oxidant-induced lung injury.

Authors:  Morgan L Locy; Lynette K Rogers; Justin R Prigge; Edward E Schmidt; Elias S J Arnér; Trent E Tipple
Journal:  Antioxid Redox Signal       Date:  2012-06-25       Impact factor: 8.401

Review 3.  The interleukin (IL)-1 cytokine family--Balance between agonists and antagonists in inflammatory diseases.

Authors:  Jennifer Palomo; Damien Dietrich; Praxedis Martin; Gaby Palmer; Cem Gabay
Journal:  Cytokine       Date:  2015-07-13       Impact factor: 3.861

Review 4.  The thioredoxin system in neonatal lung disease.

Authors:  Trent E Tipple
Journal:  Antioxid Redox Signal       Date:  2014-03-13       Impact factor: 8.401

5.  Thioredoxin-related mechanisms in hyperoxic lung injury in mice.

Authors:  Trent E Tipple; Stephen E Welty; Lynette K Rogers; Thomas N Hansen; Young-Eun Choi; James P Kehrer; Charles V Smith
Journal:  Am J Respir Cell Mol Biol       Date:  2007-06-15       Impact factor: 6.914

6.  The thioredoxin reductase-1 inhibitor aurothioglucose attenuates lung injury and improves survival in a murine model of acute respiratory distress syndrome.

Authors:  Rodney D Britt; Markus Velten; Morgan L Locy; Lynette K Rogers; Trent E Tipple
Journal:  Antioxid Redox Signal       Date:  2014-02-06       Impact factor: 8.401

Review 7.  Redox control of inflammation in macrophages.

Authors:  Bernhard Brüne; Nathalie Dehne; Nina Grossmann; Michaela Jung; Dmitry Namgaladze; Tobias Schmid; Andreas von Knethen; Andreas Weigert
Journal:  Antioxid Redox Signal       Date:  2013-03-06       Impact factor: 8.401

8.  Selenium supplementation of lung epithelial cells enhances nuclear factor E2-related factor 2 (Nrf2) activation following thioredoxin reductase inhibition.

Authors:  Rachael Tindell; Stephanie B Wall; Qian Li; Rui Li; Katelyn Dunigan; Rachael Wood; Trent E Tipple
Journal:  Redox Biol       Date:  2018-09-05       Impact factor: 11.799

Review 9.  Selenium supplementation to prevent short-term morbidity in preterm neonates.

Authors:  B A Darlow; N C Austin
Journal:  Cochrane Database Syst Rev       Date:  2003

10.  Thioredoxin Reductase-1 Inhibition Augments Endogenous Glutathione-Dependent Antioxidant Responses in Experimental Bronchopulmonary Dysplasia.

Authors:  Stephanie B Wall; Rachael Wood; Katelyn Dunigan; Qian Li; Rui Li; Lynette K Rogers; Trent E Tipple
Journal:  Oxid Med Cell Longev       Date:  2019-01-21       Impact factor: 6.543

View more
  4 in total

1.  Auranofin-Mediated NRF2 Induction Attenuates Interleukin 1 Beta Expression in Alveolar Macrophages.

Authors:  Stephanie B Wall; Rui Li; Brittany Butler; Ashley R Burg; Hubert M Tse; Jennifer L Larson-Casey; A Brent Carter; Clyde J Wright; Lynette K Rogers; Trent E Tipple
Journal:  Antioxidants (Basel)       Date:  2021-04-21

2.  Redox regulation of immunity and the role of small molecular weight thiols.

Authors:  Pietro Ghezzi
Journal:  Redox Biol       Date:  2021-05-08       Impact factor: 11.799

3.  Effect of a Nutritional Support System to Increase Survival and Reduce Mortality in Patients with COVID-19 in Stage III and Comorbidities: A Blinded Randomized Controlled Clinical Trial.

Authors:  Fernando Leal-Martínez; Lorena Abarca-Bernal; Alejandra García-Pérez; Dinnaru González-Tolosa; Georgina Cruz-Cázares; Marco Montell-García; Antonio Ibarra
Journal:  Int J Environ Res Public Health       Date:  2022-01-21       Impact factor: 3.390

Review 4.  Effects of Antioxidants in Human Milk on Bronchopulmonary Dysplasia Prevention and Treatment: A Review.

Authors:  Xianpeng Yang; Shanyu Jiang; Xianhui Deng; Zichen Luo; Ailing Chen; Renqiang Yu
Journal:  Front Nutr       Date:  2022-07-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.